International Journal of Cancer Management

Published by: Kowsar

A Dynamic Model for Predicting Prostate Cancer in Iranian Men Based on a Perceptron Neural Network

Farzad Allameh 1 , * , Hamidreza Qashqai 2 and Alborz Salavati 3
Authors Information
1 Laser Application in Medical Sciences Research Center, Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: March 2017, 10 (3); e7415
  • Published Online: March 20, 2017
  • Article Type: Research Article
  • Received: June 4, 2016
  • Accepted: March 8, 2017
  • DOI: 10.5812/ijcm.7415

How to Cite: Allameh F, Qashqai H, Salavati A. A Dynamic Model for Predicting Prostate Cancer in Iranian Men Based on a Perceptron Neural Network, Int J Cancer Manag. 2017 ; 10(3):e7415. doi: 10.5812/ijcm.7415.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Pourmand G, Ramezani R, Sabahgoulian B, Nadali F, Mehrsai A, Nikoobakht M, et al. Preventing Unnecessary Invasive Cancer-Diagnostic Tests: Changing the Cut-off Points. Iran J Public Health. 2012; 41(2) : 47 -52 [PubMed]
  • 2. Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, et al. The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev. 2007; 8(3) : 422 -8 [PubMed]
  • 3. Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, et al. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Eur Urol. 2014; 66(6) : 1109 -15 [DOI][PubMed]
  • 4. Orsted DD, Nordestgaard BG, Jensen GB, Schnohr P, Bojesen SE. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol. 2012; 61(5) : 865 -74 [DOI][PubMed]
  • 5. Carter HB. Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics. Asian J Androl. 2012; 14(3) : 355 -60 [DOI][PubMed]
  • 6. Verma A, St Onge J, Dhillon K, Chorneyko A. PSA density improves prediction of prostate cancer. Can J Urol. 2014; 21(3) : 7312 -21 [PubMed]
  • 7. Masieri L, Minervini A, Vittori G, Lanciotti M, Lanzi F, Lapini A, et al. The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml. Int Urol Nephrol. 2012; 44(4) : 1031 -8 [DOI][PubMed]
  • 8. Tanaka N, Fujimoto K, Chihara Y, Torimoto M, Hirao Y, Konishi N, et al. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels. Prostate Cancer Prostatic Dis. 2007; 10(3) : 274 -8 [DOI][PubMed]
  • 9. Saritas I, Ozkan IA, Sert IU. Prognosis of prostate cancer by artificial neural networks. Expert Syst Appl. 2010; 37(9) : 6646 -50 [DOI]
  • 10. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol. 2002; 20(4) : 921 -9 [DOI][PubMed]
  • 11. Glotsos D, Kalatzis I, Theocharakis P, Georgiadis P, Daskalakis A, Ninos K, et al. A multi-classifier system for the characterization of normal, infectious, and cancerous prostate tissues employing transrectal ultrasound images. Comput Methods Programs Biomed. 2010; 97(1) : 53 -61 [DOI][PubMed]
  • 12. Ghaderzadeh M, Sadoughi F, Ketabat A. A computer-aided detection system for automatic classification of prostate cancer from benign hyperplasia of prostate. Iranian J Med Inform. 2013; 2(2)
  • 13. Çınar M, Engin M, Engin EZ, Ziya Ateşçi Y. Early prostate cancer diagnosis by using artificial neural networks and support vector machines. Expert Syst Appl. 2009; 36(3) : 6357 -61 [DOI]
  • 14. Goss EP, Vozikis GS. Improving health care organizational management through neural network learning. Health Care Manag Sci. 2002; 5(3) : 221 -7 [DOI][PubMed]
  • 15. Hernandez DJ, Han M, Humphreys EB, Mangold LA, Taneja SS, Childs SJ, et al. Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone. BJU Int. 2009; 103(5) : 609 -14 [DOI][PubMed]
  • 16. Yousefi Kashi AS, Khaledi S, Houshyari M. CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients Iran J Cancer Prev. 2016; 9(3)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments